Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer

Antibody-recruiting molecules (ARMs) are one of the most promising tools to redirect the immune response towards cancer cells. In this review{,} we aim to highlight the recent advances in the field. We will illustrate the advantages of different ARM approaches and emphasize the importance of a multivalent presentation of the binding units.

Références

Titre
Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer
Type de publication
Article de revue
Année de publication
2021
Revue
RSC Chem. Biol.
Pagination
-
Date de publication
03/2021
Soumis le 15 mars 2021